Mexiletine Hydrochloride - CAS 5370-01-4
Catalog number: 5370-01-4
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C11H17NO.HCl
Molecular Weight:
215.72
COA:
Inquire
Targets:
Sodium Channel
Description:
Mexiletine HCl belongs to Class IB anti-arrhythmic group of medicines, inhibits sodium channels to reduce the inward sodium current.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
KO1173
MSDS:
Inquire
1.Flecainide-Responsive Myotonia Permanens With SNEL Onset: A New Case and Literature Review.
Portaro S1, Rodolico C2, Sinicropi S2, Musumeci O2, Valenzise M3, Toscano A4. Pediatrics. 2016 Mar 4. pii: peds.2015-3289. [Epub ahead of print]
Sodium channel myotonias are inherited muscle diseases linked to mutations in the voltage-gated sodium channel. These diseases may also affect newborns with variable symptoms. More recently, severe neonatal episodic laryngospasm (SNEL) has been described in a small number of patients. A timely diagnosis of SNEL is crucial because a specific treatment is now available that will likely reduced laryngospasm and improve vital and cerebral outcomes. We report here on an 8-year-old girl who had presented, at birth, with SNEL who subsequently developed myotonia permanens starting at age 3 years. Results of molecular analysis revealed a de novo SCN4A G1306E mutation. The girl was treated with carbamazepine, acetazolamide, and mexiletine, with little improvement; after switching her treatment to flecainide, she experienced a dramatic reduction in muscle stiffness and myotonic symptoms as well as an improvement in behavior.
2.Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3.
Mazzanti A1, Maragna R1, Faragli A1, Monteforte N1, Bloise R1, Memmi M1, Novelli V1, Baiardi P1, Bagnardi V2, Etheridge SP3, Napolitano C1, Priori SG4. J Am Coll Cardiol. 2016 Mar 8;67(9):1053-8. doi: 10.1016/j.jacc.2015.12.033.
BACKGROUND: Long QT syndrome type 3 (LQT3) is a lethal disease caused by gain-of-function mutations in the SCN5A gene, coding for the alpha-subunit of the sodium channel NaV1.5. Mexiletine is used to block late sodium current and to shorten QT interval in LQT3 patients.
3.A randomized trial of mexiletine in ALS: Safety and effects on muscle cramps and progression.
Weiss MD1, Macklin EA2, Simmons Z2, Knox AS2, Greenblatt DJ2, Atassi N2, Graves M2, Parziale N2, Salameh JS2, Quinn C2, Brown RH Jr2, Distad JB2, Trivedi J2, Shefner JM2, Barohn RJ2, Pestronk A2, Swenson A2, Cudkowicz ME2; Mexiletine ALS Study Group. Neurology. 2016 Feb 24. pii: 10.1212/WNL.0000000000002507. [Epub ahead of print]
OBJECTIVE: To determine the safety and tolerability of mexiletine in a phase II double-blind randomized controlled trial of sporadic amyotrophic lateral sclerosis (SALS).
4.The Complexity of Pain Management in Patients with Erythromelalgia.
Patel N1, Chen E, Cucchiaro G. A A Case Rep. 2015 Nov 1;5(9):151-3. doi: 10.1213/XAA.0000000000000201.
A 15-year-old girl diagnosed with erythromelalgia was admitted to the hospital with severe pain in her feet associated with burning, pruritus, erythema, and swelling. She had not responded to conventional management and received some relief only from cold bath immersions, which resulted in chronic blistering and multiple episodes of superinfection. After a successful trial of spinal cord stimulation, she had a permanent implantation procedure. The spinal cord stimulator relieved her pain and improved function but not the sensation of burning pain. However, this pain resolved after she started daily mexiletine. This case demonstrates that erythromelalgia sometimes can be managed successfully with a combination of pharmacologic and interventional procedures.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Sodium Channel Products


Funapide
(CAS: 1259933-16-8)

Funapide is a Nav1.7 and Nav1.8 voltage-gated sodium channel inhibitor under the development by Xenon Pharmaceuticals and Teva Pharmaceutical Industries. It is ...

CAS 61-12-1 Dibucaine Hydrochloride

Dibucaine Hydrochloride
(CAS: 61-12-1)

Dibucaine HCl is a local anesthetics.Among the most potent and toxic of the long-acting local anesthetics, current use of it is generally restricted to spinal a...

CAS 6108-05-0 Lidocaine hydrochloride monohydrate

Lidocaine hydrochloride monohydrate
(CAS: 6108-05-0)

Lidocaine hydrochloride monohydrate is the hydrochloride monohydrate form of lidocaine, which is an aminoethylamide and a prototypical member of the amide class...

CAS 1744-22-5 Riluzole

Riluzole
(CAS: 1744-22-5)

Riluzole is a drug used to treat amyotrophic lateral sclerosis.

CAS 57-41-0 Phenytoin

Phenytoin
(CAS: 57-41-0)

Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage gated sodium channels.

CAS 892546-37-1 PH-064

PH-064
(CAS: 892546-37-1)

PH-064 is a sodium channel inhibitor. It is extracted from patent FR 2879460 A1.

CAS 95635-55-5 Ranolazine

Ranolazine
(CAS: 95635-55-5)

Ranolazine is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina.

CAS 4368-28-9 Tetrodotoxin

Tetrodotoxin
(CAS: 4368-28-9)

Tetrodotoxin, frequently abbreviated as TTX, is a potent neurotoxin. Its name derives from Tetraodontiformes, an order that includes pufferfish, porcupinefish, ...

ICA-121431
(CAS: 313254-51-2)

ICA-121431 is a potent and selective inhibitor of human NaV1.3 (IC50=13 nM) and NaV1.1 channels (IC50=23 nM) with 1,000 fold selectivity against other resistant...

Eleclazine
(CAS: 1443211-72-0)

Eleclazine is a selective Sodium channel antagonist. Eleclazin showed a shortening of the QTc interval (the time interval between the start of the Q-wave and en...

CAS 84057-84-1 Lamotrigine

Lamotrigine
(CAS: 84057-84-1)

Lamotrigine is an anticonvulsant, inhibiting glutamate release, possibly through inhibition of Na+, K+ and Ca2+ currents.

T-1095
(CAS: 209746-59-8)

T-1095, with potential antidiabetic effect, is an inhibitor of renal Na+-glucose cotransporters that may provide a novel way to treating diabetes.

CAS 5875-06-9 Proxymetacaine hydrochloride

Proxymetacaine hydrochloride
(CAS: 5875-06-9)

Proparacaine Hydrochloride is a topical ophthalmic anesthetic, acting by inhibiting the voltage-gated sodium channels. IC50(ED50): 3.4 mM.

CAS 212778-82-0 Elpetrigine

Elpetrigine
(CAS: 212778-82-0)

Elpetrigine, also known as GW 273293 and JZP-4, has a blocking effect on calcium channels and potassium channels which has been in clinical bipolar disorders an...

CAS 6160-12-9 (-)-Sparteine sulfate pentahydrate

(-)-Sparteine sulfate pentahydrate
(CAS: 6160-12-9)

(-)-Sparteine sulfate pentahydrate is an alkaloid compound which could be used as in the treatment of antiarrhythmic by blocking sodium channel.

GSK-1014802 hydrochloride
(CAS: 934240-31-0)

GSK-1014802 hydrochloride is the hydrochloride form of GSK-1014802, which is a novel analgesic for the treatment of lumbosacral radiculopathy (sciatica) and tri...

XEN907
(CAS: 912656-34-9)

XEN907 is a novel spirooxindole NaV1.7 blocker with IC50 of 3 nM. It shows a further 10-fold increase in potency, which represents a promising structure for fur...

GS967
(CAS: 1262618-39-2)

GS967, also known as GS-458967, is a highly selective late sodium channel current blocker. The selective inhibition of late INa with GS967 can exert antiarrhyth...

PF-05241328
(CAS: 1387633-03-5)

PF-05241328, a purely acidic molecule, is a selective inhibitor of human Nav1. 7 voltage-dependent sodium channels (IC50= 31nM) for the treatment of pain. But P...

CAS 944261-79-4 A-803467

A-803467
(CAS: 944261-79-4)

A-803467 is a sodium channel blocker that potently blocks tetrodotoxin-resistant currents (IC50=140 nM).

Chemical Structure

CAS 5370-01-4 Mexiletine Hydrochloride

Quick Inquiry

Verification code

Featured Items